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1. Introduction 
1.1. The dipole potential of the cell membrane 
The eukaryotic cell membrane is a highly complex structure because of its lateral 
heterogeneity, the presence of membrane microdomains, and the “trinity” of membrane 
potentials, including transmembrane, surface, and dipole potentials. The least known, the dipole 
potential originates from the preferential alignment of interfacial water dipoles and dipolar 
segments of phospholipid and sterol molecules. Due to the arrangement of molecular dipoles, 
the interior part of the bilayer is characterized by a large positive potential with a magnitude of 
several hundred millivolts, resulting in a dipole electric field much stronger (108-109 V/m) than 
that of the other two membrane potentials. 
Because of this large electric field, the dipole potential influences the conformation and 
the function of membrane proteins through effects exerted on their transmembrane domains 
(TMD). Consistently, significant effects of the dipole potential on the structure and function of 
proteins have been demonstrated in bacterial ionophores, voltage gated ion channels, Na+/K+ 
ATPases, P-glycoproteins and G-protein coupled receptors. 
The magnitude of the dipole potential is mainly determined by the lipid composition of 
the cell membrane, as it is influenced by whether the hydrophobic chains of phospholipids 
contain ether or ester bonds; the presence of double bonds in phospholipid chain regions; and 
the amount of sterols in the membrane. Its magnitude can be decreased experimentally by using 
phloretin, and increased with 6-ketocholestanol. 
Because the dipole potential is entirely located within the low dielectric, hydrophobic 
interior of the plasma membrane, it is difficult to measure directly. Although several methods 
have been published to estimate the dipole potential, including measurement of the permeability 
of large hydrophobic ions, cryoelectron microscopy, molecular dynamics simulations, atomic 
force microscopy, and vibrational Stark effect spectroscopy, the application of voltage sensitive 
fluorophores represents the most widely accepted tool. Among these, the most commonly used 
molecules are the aminostyrylpyridinium derivatives, particularly di-8-ANEPPS. The 
applicability of this fluorophore is based on electrochromism (Stark effect), i.e. spectral shifts in 
response to changes in the magnitude of the local intramembrane electric field. Di-8-ANEPPS 
is mainly applied in an excitation ratiometric assay, when after exciting the dye at two different 
wavelengths corresponding to the two opposite edges of its excitation spectrum, the two emitted 
fluorescence intensities are measured and their ratio is calculated, which was shown to depend 
mostly on the magnitude of the membrane dipole potential. Under certain circumstances the use 
of another independentmethod might be beneficial when measuring the dipole potential.3-
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hydroxyflavone derivatives are good candidates in these cases due to dramatic changes in their 
emission spectra as a function of the intramembrane electric field. These fluorophores are 
characterized by two well-separated bands in their emission spectra belonging to normal (N*) 
and tautomer (T*) excited states of their flavone chromophore. Species T* appears as a result of 
an excited-state intramolecular proton transfer (ESIPT) reaction that is very sensitive to changes 
in the local electric field. The relative intensities of the N* and T* fluorescence emission bands 
can be used to measure the dipole potential of the cell membrane. Various 3-hydroxyflavone 
derivatives have been designed in which the chromophore is oriented in opposite directions with 
respect to the bilayer plane. Consistently, the N*:T* emission ratio of PPZ8 and of its related 
analog, F66, change in opposite directions upon modifying the dipole potential. Their 
simultaneous application is especially beneficial, as in the case of an alteration of another 
membrane biophysical parameter opposite changes in the spectra of the two fluorophores are 
expected. Thus, changes in the dipole potential can be differentiated from the alteration of other 
parameters. 
  
1.2. The ErbB protein family 
Members of the epidermal growth factor receptor family, the ErbB proteins 
(ErbB1=EGFR=HER1, ErbB2=HER2/Neu, ErbB3=HER3, ErbB4=HER4) belong to the group 
of receptor tyrosine kinases and are important in early embryogenesis, in the development of the 
central and peripheral nervous system, various glands, heart muscle and cardiac valves. Since 
their activation stimulates signaling processes leading to cell division, they play important roles 
in the pathogenesis of different tumors (breast, lung, ovarium, cervix, gastrointestinal 
carcinomas, glial tumors), as their mutation or overexpression may result in transformation of 
the cells. 
The ErbB proteins possess an extracellular ligand binding, a transmembrane and an 
intraceullular kinase domain. Besides their role in tumorigenesis, the major scientific interest in 
this receptor family stems from the fact that they are prototypes of dimerization-activated 
proteins. According to the classical allosteric activation model, in their resting state the receptors 
are found as monomers in the cell membrane. Binding of a ligand (for example EGF) induces a 
conformational change of the extracellular domain (ECD), leading to the homo- or 
heterodimerization of the receptor monomers, which results in the activation of the neighboring 
cytoplasmic tyrosine kinase domains through receptor-receptor interactions. This increased 
kinase activity leads to the (cross)autophosphorylation of receptor monomers and these 
phosphorylated tyrosine side chains serve as docking sites for cytoplasmic proteins. As a result 
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of binding, these adapter molecules become phosphorylated and activated, which results in the 
activation of downstream signaling pathways. According to the classical dogma, receptor 
dimerization and activation are controlled mainly by the ECD that adopts a closed conformation 
in the resting state, which is able to bind the ligand but the dimerization arm located in this region 
is buried. Ligand binding may induce a transition into the open conformation; or according to 
other theories, the conformation of the receptor may fluctuate between the closed and open states, 
and ligand may stabilize the latter one. In the resulting open conformation, association of 
receptor subunits can happen through the exposed dimerization arms. 
According to the classical activation model, the transmembrane domain (TMD), in 
contrast to the primary ECD, plays only a passive role in the process by merely acting as a 
membrane anchor. However, several lines of evidence suggest that the TMD does have a 
remarkable role in receptor activation. For example, a mutation in this region (as in the case of 
NeuT, a mutant variant of ErbB2) can significantly influence the association, thus the activation 
tendency of the receptors. Consistently, two so-called Sternberg-Gullick dimerization GxxxG 
motifs have been described in the TMD of ErbB proteins, which can mediate the dimerization 
of TMDs. The membrane helices of the members of this receptor family contain two such 
sequences (except for ErbB3) that can mediate the formation of two functionally distinct dimers. 
The C-terminal motif mediates the formation of functionally inactive dimers, while the ones 
formed through N-terminal GxxxG motifs are active, as the latter type of association induces a 
reorientation of kinase domains leading to their activation, which can activate downstream 
signaling cascades. The two transmembrane conformations can be easily converted into each 
other through a rotational movement. Based on novel observations, the activation of ErbB 
proteins can be modeled by a rotational activation model that suggests that the TMD and the 
kinase domains have intrinsic dimerization and self-activation tendency, which is counteracted 
by the tethered conformation of the extracellular domain, by the formation of inactive kinase 
dimers and by interactions of the juxtamembrane segment with anionic lipids of the membrane. 
This inhibitory mechanism is relieved by ligand binding to the extracellular domain, thus 
inducing a reorientation in the transmembrane and intracellular domain, resulting in the 
activation of the kinase domain and induction of signaling pathways. The magnitude of the 
dipole potential might influence the dimerization and activity of ErbB proteins through effects 
on their TMD. 
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1.3. Lipid rafts 
Another level of complexity of the cell membrane originates from the inhomogeneous 
lateral distribution of its lipids, which leads to the formation of membrane microdomains of 
submicron or nanometer scales, termed lipid rafts, with special lipid and protein composition, 
and supramolecular architecture. According to the classical lipid raft theory, the lateral 
association of sphingolipid and cholesterol molecules leads to the formation of these 
microdomains that are characterized by tight packing density, highly resembling the liquid 
ordered domains of model membranes in many aspects. Membrane proteins are segregated into 
or out of these areas according to their affinity for raft and non-raft lipid phases, and this 
distribution can significantly influence their functions through changing the probability of their 
interactions, and modifying their conformations. According to the initial consensus definition of 
these microdomains, “membrane rafts are small (10–200 nm), heterogeneous, highly dynamic, 
sterol- and sphingolipid-enriched domains that compartmentalize cellular processes”. According 
to this definition, the underlying mechanism of this phase separation is based on liquid–liquid 
immiscibility of certain lipid species, and proteins do not have an active contribution to the 
process. Lipid–protein assemblies arising from alternative phenomena would thus not qualify as 
rafts. However, the raft concept has been controversial from the initial description of the 
hypothesis, leading to continuous refinement of the definition. As of the most widely accepted 
recent views, the formation of rafts is actively influenced by the proteins residing in these 
microdomains, the cortical actin network according to the “picketed fence” model, and certain 
intracellular organelles (like the endoplasmic reticulum) through direct contacts with the 
membrane. 
Selective labeling of lipid rafts is possible by using certain molecules due to their 
preferential concentration in these microdomains. Although none of these markers can be 
considered ideal, the most widely used and accepted methods include transfecting cells with 
plasmids encoding glycosylphosphatidylinositol (GPI)-anchored proteins, or labeling them with 
subunit B of cholera toxin (CTX-B) that selectively binds to GM1 ganglioside or antibodies (for 
example AC8) recognizing ordered arrays of cholesterol molecules characteristic for rafts. 
Lipid rafts play important roles in a great variety of cellular processes including 
signaling, membrane trafficking, differentiation, adhesion or migration of cells, synaptic 
transmission, cytoskeletal organization or cellular entry of pathogens. Besides these effects, rafts 
can influence the function of ErbB proteins, as for example, the raft resident GM3 ganglioside 
was shown to inhibit the activation of EGFR. 
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Since lipid rafts are characterized by a special composition distinct from that of other 
regions of the membrane, and the magnitude of the dipole potential is mainly determined by the 
composition of the membrane, it seems logical to assume that the magnitude of dipole potential 
may be different in the raft and non-raft membrane microdomains. Although atomic-force 
microscopic measurements in model membranes suggested that the dipole potential is larger in 
liquid-ordered domains, and heterogeneity observed in the fluorescence signals of di-8-ANEPPS 
in living cells has been assumed to be caused by lipid rafts, explicit proof and quantitative 
analysis of this correlation has not yet been presented. 
 
1.4. Gaucher’s disease 
Alterations in the lipid composition of the membrane are associated with certain diseases. 
One such pathological condition characterized by a changed membrane composition is the most 
frequent lysosomal storage disorder, Gaucher’s disease in which glucosylceramide accumulates 
because of a deficiency of the glucocerebrosidase enzyme. Besides the neurological and 
musculoskeletal abnormalities and visceral symptoms (as hepato- and splenomegaly), the most 
pathognomic alteration is the presence of the so-called Gaucher cells that are abnormally 
activated macrophages resulting from the accumulated glycosylceramide. 
Due to the relatively low frequency of the disease and the difficulties in obtaining samples 
from patients, different model systems are commonly used in the examination of the 
pathomechanism of Gaucher’s disease. One of the most widely used tools is the application of 
monocytes differentiated into macrophages using phorbol-12-myristate-13-acetate (PMA). If 
conduritol B epoxide (CBE) is used simultaneously with PMA during the differentiation, 
macrophages develop a phenotype characteristic of Gaucher’s disease as a result of 
glucocerebrosidase inhibition. 
The changed lipid composition of the cell membrane due to enzyme deficiency has been 
demonstrated both in samples obtained from Gaucher patients and in model systems of the 
disease. Alterations in membrane composition include significantly elevated levels of ceramides, 
di- and trihexosylceramides, sphingomyelin and phosphatidylglycerol, not only in the 
lysosomes, but also in other endosomal compartments and the cell membrane, particularly in 
lipid rafts. These modified membrane compositions were suggested to play roles in the process 
of abnormal macrophage activation as well.  
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2. Objectives 
The key event of the activation of ErbB receptors is the homo- or heterodimerization of 
the proteins. Although the extracellular domain was initially suggested to be primarily important 
in the process of association, based on recent results, the transmembrane domain provides an 
active contribution as well. Since the TMD is located in the hydrophobic interior of the 
membrane, i.e. in the region of the dipole potential, changes in its magnitude may influence the 
conformation and association of these domains, thus also the activation of the receptors and the 
resulting initiation of signaling pathways. However, the importance of the dipole potential in the 
process has not been tested yet, so we set out to: 
a) determine the effects of treatments (phloretin and 6-ketocholestanol) previously 
published to modify the dipole potential in our experimental system, 
b) examine the effects of changing the dipole potential on the cell surface expression 
of EGFR and its ligand affinity, 
c) analyze the alterations in the association processes of EGFR, ErbB2 and NeuT 
proteins in response to changes in the dipole potential, 
d) test the functional consequence of the treatments above, 
e) examine if the effects depend on the presence of lipid rafts. 
Since the magnitude of the dipole potential is primarily determined by the lipid 
composition of the membrane, it is reasonable to assume that the dipole potential is larger in the 
lipid rafts possessing a special composition than in the bulk phase of the membrane. However, 
this relationship has not been demonstrated directly in living cell membranes. It seems also 
logical that the magnitude of the dipole potential can be altered in diseases characterized by a 
changed membrane composition. Thus, in the second phase we examined: 
a) the spectral changes of new voltage sensitive 3-hydroxyflavone derivatives (F66 
and PPZ8) in response to dipole potential modifying treatments, 
b) the correlations between the dipole potential-dependent intensity ratios of various 
voltage sensitive fluorophores and the intensities of raft and non-raft membrane domain markers, 
c) the magnitude of differences in the the dipole potential between different 
membrane microdomains, 
d) the alterations in the emission spectra of F66 and PPZ8 localized in rafts vs the 
bulk phase of the membrane, 
e) and the changes in the magnitude of the dipole potential in a model system of 
Gaucher’s disease, a disorder characterized by alterations in the lipid composition of the cell 
membrane (and lipid rafts, in particular). 
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3. Materials and methods 
3.1. Cell lines, treatments and transfection of cells  
In our exprements, we used human breast carcinoma-derived SKBR-3 cells expressing 
high amounts of ErbB1 and ErbB2, human epithelial carcinoma-derived A431 and cervix 
carcinoma-derived HeLa cells with high and medium levels of EGFR, respectively, Chinese 
hamster ovary (CHO) cells without ErbB expression and a modified CHO-derived cell line, F1-
4, that stably expresses the ErbB1-eGFP fusion protein. For experiments involving growth factor 
stimulation serum-starved cells were incubated with 100 ng/ml (~16 nM) of recombinant human 
EGF for 5 min at 37 °C. In certain cases, the dipole potential was increased and decreased by 
treating cells with 6-ketocholestanol and phloretin, respectively at a concentration of 100 μM for 
10 min at room temperature in the presence Pluronic F-127. 
For transient transfection, cells were lipofected using Lipofectamine 2000 or 
electroporated with Amaxa Nucleofector. In our intracellular phosphorylation measurements, 
cells were transfected with ErbB2-pcDNA3 or pSV2neuNT plasmid coding for the wild-type 
ErbB2 or the human NeuT protein, respectively, while for number&brightness experiments 
PCDNA3.1 ErbB2-short-mYFP and PCDNA3.1 ErbB2 (Val659Glu)-short-mYFP plasmids 
were used. Plasmids encoding GFP-GPI were utilized for lipid raft labeling. 
As a model of Gaucher’s disease, acute monocytic leukemia derived THP-1 cells were 
differentiated into macrophages by PMA treatment (50 ng/ml for 5 days) and the Gaucher 
phenotype was induced by a simultaneous treatment with 500 µM CBE. 
 
3.2. Labeling of the cells with dipole potential sensitive fluorophores, raft and non-raft 
markers 
Di-8-ANEPPS, F66 and PPZ8 fluorophores were applied to determine the magnitude of 
the dipole potential using confocal microscopy. Cells grown on 8-well chambered coverglass 
were labeled with 2 µM di-8-ANEPPS for 10 minutes at 12°C or with 10 nM F66 or PPZ8 for 
20 minutes on ice. 
For the visualization of lipid rafts in the membrane, cells were transfected with plasmids 
encoding GFP-GPI, labeled with 8 µg/ml AlexaFluor647-conjugated subunit B of cholera toxin 
or 10 µg/ml AC8 anti-cholesterol antibody for 20 minutes on ice. The latter antibody was 
visualized with Cy5-conjugated GAMIG Fab fragments. Labeling of non-raft membrane 
domains was carried out using 25 µg/ml AlexaFluor647-conjugated transferrin. 
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3.3. Determination of the effects of the dipole potential on EGF binding 
In order to determine the effects of the dipole potential on the EGF binding affinity of 
ErbB1, we measured the binding of tetramethylrhodamine-conjugated EGF (TAMRA-EGF) to 
the receptor using flow cytometry  after modifying the dipole potential of starved SKBR-3, A431 
or HeLa cells (non-competitive method). Cells were incubated with a dilution series of labeled 
EGF for 30 minutes on ice. Alternatively, the binding of TAMRA-EGF to ErbB1 was determined 
in the presence of different concentrations of unlabeled EGF (competitive method). Mean 
fluorescence intensities were determined in each sample and plotted as a function of the applied 
concentration of labeled or unlabeled EGF in the non-competitive and competitive methods, 
respectively. The appropriate Hill equation was fitted to the binding data, and parameters 
characterizing the EGF binding affinity were calculated. 
 
3.4. Analysis of the effects of dipole potential on the association of ErbB proteins  
First, flow cytometric Förster resonance energy transfer (FRET) measurements were 
carried out to determine the effects of changing the dipole potential on ErbB receptor 
dimerization. Untransfected SKBR-3 cells were used in the analysis of ErbB2 homoassociation 
and ErbB1-ErbB2 heteroassociation, ErbB1 homoassociation was measured in untransfected 
HeLa cells, while CHO cells were electroporated with ErbB2-pcDNA3 or pSV2neuNT plasmids 
to examine the associations of wild-type ErbB2 or NeuT, respectively. NeuT carryies a Val→Glu 
mutation in the transmembrane domain. The dipole potential of starved cells was changed and 
some of the samples were stimulated with EGF followed by labeling the cells with 
AlexaFluor546-conjugated (donor) or AlexaFluor647-conjugated (acceptor) anti-ErbB1 Ab11 
or anti-ErbB2 trastuzumab antibodies for 30 minutes on ice. Fluorescence intensities 
corresponding to donor, FRET and acceptor channels were determined on a cell-by-cell basis 
and mean FRET efficiencies characterizing the extent of association were calculated after 
applying the appropriate correction factors. 
As an alternative method to FRET measurements, the associations of the receptors were 
quantified with number&brightness (N&B) analysis of confocal images. F1-4 cells stably 
expressing ErbB1-eGFP fusion proteins were used to determine EGFR homoassociation, while 
HeLa cells were transfected with PCDNA3.1 ErbB2-short-mYFP and PCDNA3.1 ErbB2 
(Val659Glu)-short-mYFP plasmids for the investigation of ErbB2 and NeuT, respectively. The 
dipole potential of starved cells grown on 8-well chambered coverglass was modified followed 
by EGF stimulation of certain samples. Confocal image series were recorded of the cell 
membrane region adjacent to the coverslip and the mean and the variance of the fluorescence 
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intensity were determined in every membrane pixel. Finally, the average molecular brightness 
value characterizing the clustered state of the molecule was calculated from pixelwise data. 
 
3.5. Examination of the functional significance of changing the dipole potential and its 
dependence on the presence of lipid rafts 
Control starved SKBR-3 cells and those with an altered dipole potential were treated with 
EGF, fixed and permeabilized, which was followed by labeling the cells for 30 minutes on ice 
with antibodies, at a concentration of 10 g/ml, against phosphotyrosine (PY99), ErbB2 
phosphorylated at Tyr1248 (Ab18) and ErbB1 phosphorylated at Tyr1068 (1H12). Primary 
antibodies were visualized by secondary staining with 20 µg/ml AlexaFluor647-conjugated goat-
anti-mouse antibodies (GAMIG) for 30 minutes on ice. The mean fluorescence intensities of 
individual cells were determined using flow cytometry. We repeated our measurements on cells 
electroporated with ErbB2-pcDNA3 or pSV2neuNT plasmids. 
In order to examine the relationship between ErbB2 phosphorylation and the presence of 
lipid rafts, control starved SKBR-3 cells grown on 8-well chambered coverglass and those with 
an altered dipole potential were treated with EGF and labeled with AlexaFluor546-conjugated 
trastuzumab and AlexaFluor647-conjugated CTX-B for 30 minutes on ice. After fixation and 
permeabilization of these cells, Ab18 antibody against phosphorylated Tyr1248 of ErbB2 was 
applied, which was visualized with AlexaFluor488-GAMIG. Images were taken of the region of 
the cells adjacent to the coverslip using a confocal microscope. During the evaluation of images, 
membrane pixels were identified manually and segmented into two masks containing pixels with 
high or low CTX-B intensity (“CTX-high” and “CTX-low” regions, respectively). The intensity 
of Ab18 staining (corresponding to tyrosine phosphorylated ErbB2) normalized to the expression 
level of ErbB2 (trastuzumab staining) was separately calculated for the CTX-high and CTX-low 
masks corresponding to raft and non-raft domains, respectively. The Pearson correlation 
coefficients were also calculated between the Ab18 intensity and CTX staining and between 
trastuzumab intensity and CTX staining. 
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3.6. Determination of the correlation coefficient between the magnitude of the dipole 
potential and the intensity of membrane microdomain markers 
In order to determine the correlation between the magnitude of the dipole potential and 
the intensity of membrane microdomain markers, SKBR-3 and A431 cells grown on 8-well 
chambered coverglass were labeled with dipole potential sensitive fluorophores (di-8-ANEPPS, 
F66 or PPZ8) and raft (GFP-GPI, AlexaFluor647-CTX-B or AC18 and AlexaFluor647- 
GAMIG-Fab) or non-raft (AlexaFluor647-transferrin) markers, as described previously. Images 
were acquired from the flat, bottom membrane of cells adjacent to the coverslip using a confocal 
laser scanning microscope. During the evaluation of images, membrane pixels were identified 
manually and the dipole potential sensitive intensity ratios were calculated in these pixels. 
Finally, the Pearson correlation coefficients between these intensity ratios and the fluorescence 
intensities of raft or non-raft markers were determined from pixelwise data of individual cells. 
The confidence intervals of the correlation coefficients assuming no correlation between the 
analyzed parameters were also determined for each image according to the method of Costes. 
The correlation coefficient between two lipid raft labels, GFP-GPI and CTX-B, was used as a 
positive control. Alternatively, evaluation of the images was carried out by excluding the 
brightest patches with the largest intensities within the cell mask. 
 
3.7. Determination of the magnitude of the dipole potential in raft versus non-raft 
membrane regions 
In order to quantify the differences in the magnitude of the dipole potential between raft 
and non-raft membrane regions, images taken previously from the flat, bottom membrane of 
SKBR-3 and A431 cells adjacent to the coverslip were evaluated using a different approach. 
During image analysis, cell membrane pixels were identified manually and segmented into two 
masks by determining a threshold intensity for lipid raft labels (CTX-B or GFP-GPI), confirmed 
by visual inspection. Pixels were considered “raft” or “nonraft” pixels if their intensity was above 
or below the determined threshold, respectively. Finally, average dipole potential sensitive di-8-
ANEPPS and F66 intensity ratios were separately determined from individual pixels in the “raft” 
and “nonraft” regions. Alternatively, using the lambda mode of the confocal laser scanning 
microscope, the emission spectrum of F66 or PPZ8 was determined separately inside and outside 
lipid rafts in a manner identical to what was described for the intensity ratio. 
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3.8. Determination of the magnitude of the dipole potential in control versus Gaucher-
type THP-1-derived macrophages 
THP-1 monocytes were differentiated into macrophages by PMA treatment. As a mdoel 
system of the disease, CBE was applied simultaneously with the differentiation to induce the 
Gaucher phenotype. The average dipole potential was determined in control and Gaucher-type 
macrophages using di-8-ANEPPS, F66, or PPZ8 labeling, followed by acquiring images from 
the midplane of the cells. During processing, segmentation of images into membrane and non-
membrane pixels was carried out and the average fluorescence intensity ratio of the cell 
membrane pixels, characterizing the dipole potential, was calculated after background 
subtraction. 
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4. Results 
4.1. The effects of 6-ketocholestanol and phloretin on the magnitude of the dipole 
potential  
Although the dipole potential has been shown to influence the structure and function of 
transmembrane proteins, ErbB receptors have not been examined in this aspect. Thus, in the first 
phase of our experiments we examined whether changes in the magnitude of the dipole potential 
can modifiy the function of ErbB proteins, namely EGFR and ErbB2. According to previous 
studies, the dipole potential of living cell membranes can be increased and decreased with 6-
ketocholestanol and phloretin, respectively. First, we tested the applicability of these compounds 
by measuring the magnitude of the dipole potential with a confocal microscopic method using 
an excitation ratiometric approach with the voltage sensitive fluorophore di-8-ANEPPS. After 
dipole potential modifying treatments, SKBR-3, A431 and HeLa cells were labeled with di-8-
ANEPPS and images were taken from the midplane of the cells with a confocal laser scanning 
microscope. During image processing, mean fluorescence intensity ratios of membrane pixels 
were determined after excitation at two different wavelengths. Consistent with our expectations, 
6-ketocholestanol significantly increased, whereas phloretin decreased the excitation intensity 
ratio proportional to the magnitude of the dipole potential of the plasma membrane in all cell 
types used. Based on these measurements, 6-ketocholetanol and phloretin were shown to be 
useful in changing the dipole potential, so we proceeded to investigate the effect of these 
alterations on the clustering and signaling properties of ErbB plasma membrane receptors. 
 
4.2. The effect of changing the dipole potential on the ligand binding affinity of EGFR 
As ligand binding is the first step of the functional activation of EGFR, we examined if 
changing the dipole potential results in alteration of ligand binding properties of ErbB1. After 
modifying the magnitude of dipole potential in SKBR-3, A431 and HeLa cells, the dissociation 
constant characterizing the binding affinity of EGF to ErbB1 was determined by competitive and 
non-competitive binding assays using fluorescently labeled EGF. First, in non-competitive 
experiments, after labeling cells with a dilution series of TAMRA-EGF, mean cellular intensities 
of the samples were measured using flow cytometry. Dissociation constants were determined by 
analyzing the binding curves fitted to the Hill equation using the obtained data points. According 
to our measurements, increasing the dipole potential significantly decreased the EGF binding 
affinity of ErbB1. 
Since incorporation of a fluorescent dye may alter the interaction of EGF with the dipole 
potential, competitive binding experiments were carried out to exclude the possibility that the 
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observed inhibited binding of EGF at a high dipole potential was due to the presence of the 
fluorescent label. Competitive binding curves were measured as described above, but the dilution 
series contained unlabeled EGF mixed with a constant concentration of labeled EGF. Based on 
our results, the binding affinity of unlabeled EGF was reduced by a high dipole potential to a 
similar extent as for fluorescent EGF. 
Next, the binding of fluorescent EGF was tested under conditions used for further 
stimulation experiments. After altering the dipole potential, cells were incubated with 100 ng/ml 
TAMRA-EGF and mean cellular intensities of the samples were measured using flow cytometry. 
In order to test the dependence of the observed effect on temperature, experiments were carried 
out either on ice or at 37 °C. The binding of fluorescent EGF was reduced by ~50% at an elevated 
dipole potential in the case of both conditions. These results were in good agreement with 
predictions based on the previously determined binding curves. 
Since decreased EGF binding can be theoretically caused by lower cell surface 
expression of ErbB1, we determined the amount of the receptor in the cell membrane after 
phloretin and 6-ketocholestanol treatments. After incubation with these compounds, cells were 
labeled with AlexaFluor546-conjugated anti-ErbB1 Ab11 monoclonal antibodies and the mean 
cellular fluorescence intensities were measured in each sample. Although EGF binding was 
significantly modified by the dipole potential, ErbB1 expression was not changed as shown by 
the unaltered binding of Ab11, which convincingly showed that the ligand binding ability of the 
receptor was significantly inhibited by an elevated dipole potential. 
 
4.3. The effect of the dipole potential on the clustering of ErbB1 and ErbB2  
Since transmembrane signaling induced by EGF is preceded by clustering of ErbB 
receptors, we investigated whether alterations in the dipole potential have any effect on receptor 
oligomerization in quiescent or stimulated cells. In these experiments, the levels of associations 
were determined by two methods: flow cytometric FRET measurements and number&brightness 
(N&B) analysis using confocal microscopy. 
According to both FRET and N&B experiments, the dipole potential exerted only minor 
effects on the homoassociation of ErbB1 and ErbB2 in non-stimulated cells. ErbB1 was mainly 
monomeric in unstimulated cells, since the molecular brightness of ErbB1-EGFP (0.07) was 
comparable to that of monomeric EGFP (0.06). On the other hand, ErbB2 formed clusters even 
in quiescent cells judged from the almost threefold difference between the molecular brightness 
of ErbB2-mYFP (0.08) and that of monomeric mYFP (0.032). Homoclustering of the TMD 
mutant NeuT was significantly enhanced even in unstimulated cells by an elevated dipole 
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potential according to both FRET and N&B measurements. Although the homoclustering of 
transfected wild-type ErbB2 was also increased by the dipole potential according to FRET 
measurements, this effect was less significant than that on NeuT (15% and 52% 6-
ketocholestanol-induced relative increase in the FRET efficiency for wild-type ErbB2 and NeuT, 
respectively). 
Contrary to resting cells, an elevated dipole potential significantly and systematically 
promoted the EGF-induced homoassociation of ErbB1 and ErbB2 according to both FRET and 
N&B measurements. Although a decrease in the dipole potential had a less predictable effect, 
EGF-induced homoclustering of ErbB2 was significantly inhibited by phloretin.  
An elevated dipole potential exerted an approximately 2-times larger effect on the EGF-
induced homoclustering of NeuT as compared to that on wild-type ErbB2 according to FRET 
and N&B measurements. The relative, 6-ketocholestanol-induced change in the FRET values in 
EGF-stimulated samples were 19% and 40% for wild-type ErbB2 and NeuT, respectively, and 
the 6-ketocholestanol-induced rise in the molecular brightness values were 13% and 33% under 
the same two conditions. 
Since ErbB2 is the preferred heterodimerization partner of EGF-activated ErbB1, the 
investigation of the effect of the dipole potential on clusters of ErbB1 and ErbB2 would be 
incomplete without measuring their heteroassociation.  
According to flow cytometric FRET measurements, the dipole potential did not have any 
effect on the heteroclustering of ErbB1 with ErbB2 in quiescent cells, while the EGF-induced 
increase in the interaction of the two receptors was significantly higher in cells in which the 
dipole potential was elevated. Based on these results we concluded that the homo- and 
heteroassociations of ErbB1 and ErbB2, especially in ligand-stimulated cells, show a positive 
correlation with the dipole potential. 
 
4.4. The effect of changing the dipole potential on EGF induced signaling 
Ligand-induced clustering of ErbB proteins leads to phosphorylation of tyrosine residues 
in the receptors and spreading of the tyrosine phosphorylation signal. In order to test whether the 
dipole potential-related changes observed in the clustering of ErbB1 and ErbB2 are mirrored in 
their signaling, the level of tyrosine phosphorylation was determined in quiescent and EGF-
stimulated cells using antibodies against phosphotyrosine (PY99), ErbB1 phosphorylated at 
Tyr1068 (1H12) and ErbB2 phosphorylated at Tyr1248 (Ab18). For these measurements, after 
modification of the dipole potential and EGF stimulation of certain samples, SKBR-3 cells were 
labeled with the previously desribed primary antibodies that were visualized with Alexa647-
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conjugated GAMIG secondary antibodies followed by determination of mean cellular 
fluorescence intensities in each sample using flow cytometry. We repeated our experiments 
using HeLa cells tranfected without any plasmid, or with ErbB2-pcDNA3 or pSV2neuNT 
plasmids encoding wild-type ErbB2 and NeuT proteins, respectively. 
Based on our results, alteration of the dipole potential did not modify the low level of 
tyrosine phosphorylation in unstimulated cells, while the EGF-induced response was correlated 
with the dipole potential. Similar to the FRET and N&B measurements, the effect of the dipole 
potential on NeuT was more pronounced than on wild-type ErbB2. We concluded that the growth 
factor-induced tyrosine phosphorylation response of cells was also significantly modified by the 
dipole potential. 
 
4.5. Correlation between the activation of ErbB2, its lipid raft localization and the dipole 
potential 
Since the dipole potential is assumed to be different in lipid rafts than in the rest of the 
membrane, some sort of correlation can be expected between the activation state of ErbB2, its 
raft localization and the dipole potential. In order to examine this correlation, control serum-
starved cells and those with an increased dipole potential were stimulated with EGF followed by 
staining with AlexaFluor546-conjugated trastuzumab and AlexaFluor647-conjugated CTX-B. 
Afterwards, cells were fixed and labeled with Ab18 antibodies against phosphorylated ErbB2, 
which was visualized by AlexaFluor488-conjugated GAMIG. Confocal images were taken of 
the cell membrane regions adjacent to the coverslip. During image analysis, cells were manually 
identified and membrane regions were segmented into two masks corresponding to high and low 
CTX intensities. The intensity of Ab18 staining (corresponding to tyrosine phosphorylated 
ErbB2) normalized to the expression level of ErbB2 (trastuzumab staining) was separately 
calculated for the high-CTX and low-CTX masks corresponding to raft and non-raft domains, 
respectively. Besides this, the Pearson correlation coefficient was calculated between the Ab18 
intensity and CTX staining and between trastuzumab intensity and CTX staining. 
In cells with an unmodified dipole potential there was no difference between the 
normalized tyrosine phosphorylation of ErbB2 inside and outside lipid rafts. Increasing the 
dipole potential enhanced the activation state of ErbB2 and it did so more pronouncedly outside 
lipid raft regions. EGF stimulation led to ErbB2 tyrosine phosphorylation both inside and outside 
lipid rafts in cells with an unmodified dipole potential and the increase was larger in regions 
outside lipid rafts. EGF stimulation in cells with an increased dipole potential did not increase 
the normalized tyrosine phosphorylation of ErbB2 further.  
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Our results suggested that the 6-ketocholestanol-induced increase in the dipole potential 
elevates ErbB2 tyrosine phosphorylation more significantly outside lipid rafts. The fact that EGF 
stimulation led to a larger rise in ErbB2 tyrosine phosphorylation outside lipid rafts suggests that 
the growth factor either preferentially activates ErbB2 outside lipid rafts or activated ErbB2 
migrates out of lipid rafts. This assumption was corroborated by a significant decrease in the 
correlation coefficient between phosphorylated ErbB2 and CTX staining upon EGF and 6-
ketocholestanol treatments, while the effects on the correlation between ErbB2 and CTX 
intensities were less substantial. In conclusion, the results suggest that activation of ErbB2 by 
either EGF or increased dipole potential preferentially takes place outside lipid rafts. 
 
4.6. The response of emission ratiometric dyes to changes in the dipole potential 
Our observations in the first phase of our work suggested that lipid rafts might play a role 
in the effects of the dipole potential on ErbB proteins. Although it was hypothesized earlier that 
due to their special lipid composition the magnitude of the dipole potential is larger in membrane 
rafts than in the bulk phase of the membrane, this assumption has not been demonstrated directly 
in living cells. Thus, in the second phase of our experiments, we set out to prove that the dipole 
potential is indeed stronger in lipid rafts than in non-raft membrane regions. To do so, it was 
necessary to find methods suitable to demonstrate the difference in the magnitude of the dipole 
potential between the two regions, and to rule out the possibility that changes in other membrane 
biophysical parameters (for example fluidity) can result in the observed differences between the 
two microdomains. Thus, we needed to supplement our measurements applying di-8-ANEPPS 
in an excitation ratiometric method. Two novel 3- hydroxyflavone derivatives, the PPZ8 and F66 
fluorophores appeared to be good candidates for this purpose using emission ratiometric assays, 
especially when both of them are applied in the same experimental system, since their 
chromophores are oriented in opposite directions with respect to the bilayer plane. As a result, 
their spectral changes are complementary to each other upon alterations in the intramembrane 
electric field. However, the direction of spectral changes due to alterations of another parameter 
(for example fluidity) are alike in the case of both dyes. Thus, in the first part of the second phase 
of our experiments, we tested whether two oppositely oriented voltage-sensitive fluorophores, 
PPZ8 and F66, are suitable for determining changes in the dipole potential in living cell 
membranes. We treated A431 and SKBR-3 cells with 6-ketocholestanol, and after labeling we 
recorded images from the flat membrane of the cells adjacent to the coverslip. We measured 
fluorescence emission in two wavelength ranges, corresponding to the N* and T* bands, and the 
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ratio of the two intensities correlating with the magnitude of the dipole potential was determined 
on a pixel-by-pixel basis.  
Consistent with our expectations, 6-ketocholestanol significantly increased the N*:T* 
intensity ratio of PPZ8, while decreasing it in the case of F66. Both the shift in the pixelwise 
distribution of the emission ratio and changes in its mean confirmed that PPZ8 and F66 can be 
used to determine changes in the dipole potential in living cells via an emission ratiometric 
method using confocal microscopy. 
 
4.7. Correlation of the dipole potential with the distribution of markers for raft and non-
raft domains 
In order to test the hypothesis that the largely different lipid composition of rafts leads to 
a higher dipole potential compared to the bulk phase of the membrane, we determined the 
correlation coefficients between the dipole potential sensitive ratiometric responses of three dyes 
(di-8-ANEPPS, PPZ8 and F66) and the intensities of three commonly used lipid raft markers 
(AlexaFluor647-labeled CTX-B, GFP-GPI and anti-cholesterol AC8 antibody) in the 
membranes of living A431 and SKBR-3 cells. The chromophore groups of PPZ8 and di-8-
ANEPPS are oriented parallel to each other, whereas the fluorophore of F66 is aligned in the 
opposite direction.  
First, as a positive control, we determined the correlation coefficient between two widely 
accepted raft markers. Cells were transfected with plasmids encoding GFP-GPI and labeled with 
CTX-B, and images were recorded of the flat, bottom membrane region adjacent to the coverslip. 
The mean Pearson correlation coefficient between the pixelwise intensities of the two raft 
markers was 0.55 in A431 and 0.48 in SKBR-3 cells. The fact that these correlation coefficients 
are far outside the confidence intervals of the correlation coefficient, assuming no correlation, 
confirms a strong positive correlation and allowed us to conclude that the method can be used to 
examine the correlation between two signals in living cells. 
Then, we determined the relationship between the dipole potential and the intensity of 
raft markers. Cells were labeled by one of the three dipole potential sensitive fluorophores, the 
intensity ratios proportional to the dipole potential were determined on a pixel-by-pixel basis, 
and their correlations with the intensities of the raft markers (CTX-B, GFP-GPI, or anti-
cholesterol antibody) were calculated. The excitation ratio of di-8-ANEPPS showed a positive 
correlation with each of the lipid raft markers. On the contrary, the F66 N*:T* emission ratio 
correlated negatively with the intensity of CTX-B. The statistical significance of these findings 
is supported by the fact that the calculated correlation coefficients were outside the confidence 
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intervals determined for the absence of correlation. Their biological significance is underlined 
by the fact that the correlation coefficients between the dipole potential and the raft markers are 
similar to what was determined in the case of the positive control. We also investigated the 
relationship between the dipole potential reported by PPZ8 and the lipid raft marker, CTX-B, 
and a negative correlation was observed. Because the chromophore in F66 is oriented oppositely 
to that in di-8-ANEPPS and PPZ8 with respect to the membrane bilayer, the dipole potential 
correlates positively with the intensity ratio of di-8-ANEPPS and PPZ8 and negatively with the 
emission ratio of F66. It follows from this relationship that the results obtained with the two 
oppositely oriented dipole potential-sensitive fluorophores, di-8-ANEPPS and F66, imply that 
the magnitude of the dipole potential correlates with the presence of raft microdomains, whereas 
the results obtained with PPZ8 contradict this conclusion, which will be resolved later. 
In order to get an independent confirmation of our results, we also investigated the 
relationship between a non-raft marker, transferrin receptor, and the dipole potential. Consistent 
with our previous findings, the excitation ratio of di-8-ANEPPS correlated negatively with the 
distribution of fluorescently labeled transferrin in both SKBR-3 and A431 cells, implying that 
the dipole potential is indeed weaker in nonraft domains than in rafts. 
 
4.8. The magnitude of the dipole potential in lipid rafts and other membrane regions 
Although the results presented in the previous section convincingly show that the dipole 
potential correlates positively with the localization of lipid rafts, they do not reveal how much 
the dipole potential differs in lipid rafts and in the bulk phase of the membrane. We quantified 
this difference using an alternative approach. Similar to the previous method, cells transfected 
with plasmids encoding GFP-GPI or labeled with CTX-B were stained with the dipole potential-
sensitive dyes di-8-ANEPPS or F66. Images acquired from the bottom of the cells were 
segmented into “raft” and “non-raft” regions on the basis of their GFP-GPI or CTX-B intensities. 
The average di-8-ANEPPS or F66 intensity ratios were separately determined for individual 
pixels in the “raft” (CTX-B high and GFP-GPI high) and “non-raft” regions, and the ratio 
determined for the raft region was normalized to that calculated for the non-raft region in every 
cell. 
Consistent with our previous results, the di-8-ANEPPS excitation ratio was significantly 
higher in raft regions than in non-raft regions in both A431 and SKBR-3 cells, whereas an 
opposite relationship was revealed when determining the emission ratio of F66, which was 
significantly smaller in rafts. Given the opposite orientation of the fluorophores in the two dipole 
potential sensitive dyes, both of these findings imply that the dipole potential is higher in rafts 
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than in the rest of the membrane. These observations confirmed the hypothesis that the 
magnitude of the dipole potential is larger in raft microdomains than in other regions of the living 
cell membrane. 
 
4.9. The emission spectra of 3-hydroxyflavone dyes in lipid rafts and other membrane 
regions  
We also measured the emission spectra of the 3-hydroxyflavone dyes inside and outside 
lipid rafts to estimate the magnitude of the spectral changes between different membrane regions. 
After labeling the cells as described previously, the emission spectrum was measured for each 
individual pixel, and they were separately averaged for pixels in the raft and non-raft regions. 
The most notable difference between the two spectra was the significantly lower intensity in the 
non-raft regions compared with raft pixels, possibly because of water-induced quenching of 
fluorescence outside rafts. Another important difference was that although both the N* and T* 
species contribute significantly to the emission of F66 in the 460–520 and 550–600 nm regions, 
respectively, PPZ8 exhibits practically no peak in the spectral region corresponding to the N* 
species. This phenomenon can explain the inability of PPZ8 to faithfully report the dipole 
potential difference inside and outside lipid rafts. 
Then, we determined the emission ratio of F66 inside and outside rafts by integrating the 
emission spectrum in the spectral range corresponding to the N* and T* species both in the 
presence and absence of 6-ketocholestanol treatment. The results implied that 6-ketocholestanol 
changes the emission ratio of F66 approximately to the same extent inside and outside rafts, 
suggesting that it increases the dipole potential similarly in both membrane microdomains. 
 
4.10. Changes in the dipole potential in response to sphingolipid accumulation 
characteristic of Gaucher’s disease 
Because the magnitude of the membrane dipole potential is mainly determined by the 
lipid composition, it can be altered in diseases in which the composition of the cell membrane 
changes. Since Gaucher’s disease has been shown to lead to significant alterations in the lipid 
content of cell membranes in general and lipid rafts in particular, we tested whether these 
changes are substantial enough to alter the dipole potential in an in vitro model of Gaucher 
disease. Control and Gaucher-type, THP1-derived macrophages were labeled with the voltage 
sensitive di-8-ANEPPS, PPZ8, or F66 dyes followed by acquiring confocal microscopic images 
in which the fluorescence intensity ratio, characteristic of the dipole potential, was evaluated in 
the identified membrane pixels only. 
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CBE treatment, inducing the Gaucher phenotype, led to a significant increase in the 
excitation ratio of di-8-ANEPPS and in the emission ratio of PPZ8, while causing a significant 
decrease in the emission ratio of F66. Results obtained with the three different dipole potential 
sensitive fluorophores strongly support that sphingolipid accumulation, characteristic of 
Gaucher’s disease, significantly increases the magnitude of dipole potential in the cell 
membrane. Our findings suggest that relevant changes in the raft-like lipid composition due to 
pathological conditions can change the dipole potential in living cells, which might possibly play 
a role in the pathomechanism of these diseases. 
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5. Discussion 
5.1. The relationship between lipid rafts and ErbB proteins 
Although creating the largest electric field, the dipole potential is the least known of the 
three described membrane potentials. Despite being shown to modify the structure and function 
of transmembrane proteins by influencing the stability and conformation changes of their TMD, 
the effects of the dipole potential have not been examined on the function of receptor tyrosine 
kinases. Since the TMD was suggested to play an active role in the action of ErbB proteins, the 
assumption seems indeed logical that the dipole potential might influence the function of these 
receptors. 
Thus, in the first part of our experiments, we examined the effects of the dipole potential 
on the function of ErbB proteins, and by using flow cytometric FRET measurements and N&B 
analysis of confocal microscopic images we showed that the dipole potential is significantly 
correlated with the homo- and heteroclustering of ErbB1 and ErbB2. The effect was 
systematically observed in EGF-stimulated cells, whereas changes in the dipole potential did not 
exert substantial effects on ErbB1 and ErbB2 in unstimulated cells. The increased growth factor-
induced association of ErbB proteins at an elevated dipole potential was correlated with 
enhanced signaling, as confirmed with measurements of receptor phosphorylation levels. 
However, the fact that increased signaling at an elevated dipole potential was associated with 
reduction of ligand binding was unexpected. If this suppressed ligand binding at an elevated 
dipole potential is taken into account, the dipole potential-induced augmentation of the EGF 
effect is even larger since a lower amount of bound ligand brings about the larger changes in the 
clustering and phosphorylation of ErbB1 and ErbB2. This apparent contradiction can be resolved 
by assuming that the increase of the dipole potential favors the active conformation of the 
transmembrane domain dimers, which eventually induces conformational transitions in the 
extra- and intracellular domains as well resembling or identical to those induced by growth factor 
binding.  
Lipid rafts are important in EGF-mediated signaling since both ErbB1 and ErbB2 have 
been shown to be raft resident. These microdomains are presumed to play a bipartite role in the 
clustering and signaling of ErbB proteins, since they inhibit ligand binding but potentiate growth 
factor-induced signaling at the same time. Our results show that the effects of the dipole potential 
exactly mirror the bipartite effect of lipid rafts. The dipole potential-induced activation of ErbB2 
was more pronounced outside lipid rafts, while the magnitude of increase in the dipole potential 
induced by 6-ketocholestanol treatment is similar in different membrane microdomains. This 
might be caused by the fact that the magnitude of the dipole potential might be high enough in 
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rafts to stabilize the conformation of the TMD permissive for dimerization, even in the absence 
of 6-ketocholestanol. However, the weaker dipol potential in non-raft microdomains might be 
unable to stabilize the conformation of TMD required for dimerization. Thus, increasing the 
dipole potential can exert a substantial effect on dimerization and activation. 
We considered six possible models for explaining the phenomenon that the dipole 
potential only affects ligand-induced clusters without influencing constitutive ones. 
1. The dipole potential may only exert a permissive effect on clustering, which is not strong 
enough for altering the weak and transient constitutive dimers or oligomers. 
2. It has been suggested that constitutive dimers or oligomers are generated by corralling or 
confinement by the cytoskeleton, while actively signaling receptor clusters are held together 
by protein-protein interactions. Since it is unlikely that the membrane dipole potential affects 
corralling and confinement, it only exerts effects on ligand-induced clusters.  
3. The interactions between the electric fields generated by the atoms play important roles in 
the stabilization of the α-helical structure of TMDs because of the large dipole moments of 
peptide bonds. TMDs can actively influence the association, thus the activation of membrane 
proteins via their specific dimerization motifs, for example the Sternberg-Gullick GxxxG 
consensus sequence. The TMDs of ErbB proteins (except for ErbB3) contain two such 
GxxxG motifs that mediate the formation of two distinct dimers with different 
conformations. These two can easily transition into each other by a simple sliding movement 
and a rotation of 120 degrees. The GxxxG sequence closer to the C-terminal of the helix 
mediates the formation of a functionally inactive dimer, while dimers associated through the 
N-terminal motif are functionally active. According the most widely accepted rotational 
activation model, the equilibrium between the two functionally different dimers is shifted 
towards active dimerization in response to ligand binding, which leads to the activation of 
intracellular domains of receptor subunits. Our experimental results completely fit into this 
theory. The effects of dipole potential on receptor association can be explained by the fact 
that parallel α-helices, present in dimers of single-pass transmembrane proteins, exert a 
repulsive electrostatic force on each other. According to our semiquantitative model, the 
magnitude of the electric potential difference behind this effect is comparable to that of the 
membrane dipole potential. Increasing the dipole potential may counteract the repulsion 
between the N-termini of helices, which would lead to the stabilization of the interaction 
between the N-terminal dimerization motifs. On the other hand, the dipole potential does not 
exert such an effect on the C-terminal motifs oriented parallel with the dipole potential. Thus, 
the equilibrium between the two forms can be shifted towards formation of active dimers in 
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response to an increase in dipole potential. Since the importance of such interhelical 
interactions between TMDs has been described in a great variety of membrane proteins (for 
example integrins, cytokine receptors, other receptor tyrosine kinases), our theory could be 
applied to these proteins as well. Assuming that our hypothesis is correct, the magnitude of 
the dipole potential might influence the association processes of many biologically relevant 
molecules in the membrane of living cells. 
4. Exposure of the TMD helix termini to water decreases their dipole moment and the resulting 
repulsion between them due to a phenomenon called “solvent screening”. Consequently, if 
the increase of dipole potential is associated with decreased membrane thickness, less 
repulsion between TMDs would favor receptor clustering, thus explaining our results. 
However, it has been shown that neither phloretin, nor 6-ketocholestanol changes the 
membrane thickness arguing against this model. 
5. Consistent with the rotational activation model, the role of the juxtamembrane domain (JMD) 
has been demonstrated in the dimerization and the resulting activation of ErbB proteins. The 
antiparallel dimer formation between the N-terminal α-helical juxtamembrane (JM-A) 
segments directly connected to TMD dimers is necessary for the asymmetrical dimer 
formation of the kinase domains, which is required for their activation. However, interaction 
between the positively charged lysine and arginine amino acids of the JM-A segments and 
kinase domains and the anionic lipids in the inner leaflet of the cell membrane results in 
anchoring these regions to the membrane, which leads to the inactivation of kinase domains 
by making the formation of JM-A antiparallel dimers impossible, thus  inhibiting activation 
of the receptors. TMDs are also important in formation of the active conformation, since the 
C-termini of transmembrane helices move apart because of the association via the N-terminal 
GxxxG motifs, which results in the dissociation of JM-A segments from the membrane. The 
presence of ECD inhibits TMD dimer formation mediated by the N-terminal motifs, since it 
keeps away the N-termini of transmembrane helices from each other. Ligand binding results 
in a conformational change of the ECD, which in turn releases the inbition of TMDs, thus 
inducing the formation of active TMD dimers and the activation of the kinase domains. 
The dipole pontential can modify this process by promoting the interaction between the N-
terminal dimerization motifs of TMDs, as described previously, and by directly influencing 
the conformation of JMDs. Since the JMD is embedded in the hydrophobic core of the 
membrane, the positively charged lysine residues in the JM-A segment may be repelled by 
the positive lobe of the dipole potential, thus decreasing the stability of the inhibited 
conformation. In this way, an increased dipole potential may destabilize the membrane 
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embedding of the JM-A segment favoring the formation of JMD dimers and the activation 
of kinase domains. 
6. Changes in the dipole potential and consequent alterations in lipid-protein interactions may 
change the distribution of ErbB receptors between raft and non-raft domains. The majority 
of studies found that lipid rafts inhibit ligand binding and signaling mediated by ErbB1 and 
that activation takes place upon concomitant migration of ErbB1 out of lipid rafts. Our results 
imply that activation of ErbB2 by EGF preferentially takes place outside rafts and an 
increased dipole potential mimics this effect. Therefore, dipole potential-induced 
redistribution of receptors can also enhance their association and signaling. 
By one or more of these mechanisms, ErbB monomers become prone to dimerization 
after an elevation in the dipole potential. In this way, more monomers are available to form 
homo- and heterodimers after growth factor stimulation. Therefore, EGF-induced formation of 
ErbB1-2 heterodimers does not lead to decreased homoassociation of ErbB1 or ErbB2 because 
the dimers are formed from the dimerization-prone pool of monomers. 
The dipole potential may also have implications for the evolution and treatment of cancer. 
Tumor cells are characterized by an increased raft density and the higher dipole potential in these 
membrane regions may activate receptor tyrosine kinases in cancer cells. This implies that 
attenuation of signaling upon lowering the dipole potential may even have therapeutic 
implications. Our observation emphasize that effects of the dipole potential must not be ignored 
when examining the effects of membrane environment on receptor clustering. 
  
5.2. The relationship between the dipole potential and lipid rafts 
Because cholesterol, membrane compactness, and lipid order have been shown to affect 
the dipole potential, it was reasonable to assume that the dipole potential is different in liquid-
ordered, raft-like membrane microdomains than in the bulk membrane. Although observations 
supporting this hypothesis have been described in model membranes, and using indirect methods 
in living cells as well, the correlation has not been demonstrated directly and quantitatively in 
the membrane of living cells. Therefore, the major aims of the second phase of our work were 
a) to present evidence for the difference in the dipole potential inside and outside lipid rafts; b) 
to estimate the magnitude of this difference; and c) to show how large an effect the altered lipid 
composition of the plasma membrane in metabolic disorders (e.g., Gaucher disease) has on the 
dipole potential. 
Using quantitative evaluation of the Pearson correlation coefficients between the 
intensities of three different lipid raft markers (GFP-GPI, fluorescently labeled subunit B of 
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choleratoxin and AC8 antibody against ordered cholesterol array) and the dipole potential 
sensitive intensity ratios of voltage sensitive dyes (di-8-ANEPPS and F66), we showed that the 
dipole potential is positively correlated with the presence of lipid rafts. An independent 
confirmation of the difference in the magnitude of the dipole potential inside and outside rafts 
was provided by staining non-raft domains with fluorescently labeled transferrin, showing that 
the dipole potential is significantly weaker in transferrin-labeled nonraft domains than in lipid 
rafts. The significance of these correlations was evaluated in two ways. The methodological or 
technical significance was corroborated by the fact that the correlation coefficients were always 
outside the 95% confidence intervals calculated for the absence of correlation. To appreciate the 
biological significance of the finding, as a positive control, we determined the correlation 
coefficient between two widely accepted lipid raft markers (GFP-GPI and CTX-B). Because the 
correlation coefficients between the dipole potential and lipid raft markers were similar in 
magnitude to the positive control, we conclude that the observed correlation is strong and 
biologically meaningful. 
Evaluation of the dipole potential sensitive intensity ratios inside and outside lipid rafts 
enabled us to estimate the magnitude of the lipid raft-dependent increase in the dipole potential. 
Because a 15% change in the excitation ratio of di-8-ANEPPS represents a 100 mV change in 
the dipole potential, a difference of ~7% in the excitation ratio of di-8-ANEPPS measured inside 
and outside lipid rafts corresponds to a ~50 mV alteration in the dipole potential. An independent 
way of estimating the magnitude of the raft-dependent increase in the dipole potential is to 
compare the changes in the emission ratio of F66 induced by 6-ketocholestanol and by the 
presence of lipid rafts. Therefore, we analyzed the dipole potential and its 6-ketocholestanol-
induced alteration inside and outside lipid rafts by using a more reliable indicator, F66. 
6-ketocholestanol decreased the emission ratio of F66 by ~35% both inside and outside lipid 
rafts, implying that its effect on the dipole potential is identical in both domains of the membrane. 
Based on our previous measurements, 6-ketocholestanol induces a ~25% increase in the 
excitation ratio of di-8-ANEPPS, corresponding to a ~160-170 mV change in the dipole potential 
according to the calibration published in the literature. Assuming that the 35% change in the 
emission ratio of F66, induced by 6-ketocholestanol, corresponds to a 160–170 mV difference 
in the dipole potential, a difference of ~20% in the emission ratio of F66 observed inside and 
outside lipid rafts is equivalent to a difference of ~100 mV in the dipole potential. Given the 
large variation in the calculated or measured values of the dipole potential in the literature, the 
two estimations outlined above are in reasonable agreement with each other. 
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Although the correlations among three lipid raft markers, GFP-GPI, CTX-B, and the anti-
cholesterol antibody, and two dipole potential sensitive indicators, F66 and di-8-ANEPPS, imply 
the existence of a stronger dipole potential in lipid rafts, the results obtained with the indicator 
PPZ8 are in disagreement with those collected with the other indicators. In order to explain this 
contradiction, the photophysical properties of 3-hydroxyflavone dyes, F66 and PPZ8, must be 
taken into account. These dyes are present in two different ground-state forms: 1) a hydrogen-
bonded form (hydrated, H-N); and 2) a nonhydrogen-bonded form. The latter one undergoes 
ESIPT to produce emission from two different molecular species, the normal form (N*) and its 
tautomeric variant (T*). The ratio of emission from the N* and T* species is sensitive to the 
dipole potential. Besides the dipole potential, other factors also affect the fluorescence of 3-
hydroxyflavone dyes: 1) the relative contribution of the H-N species depends on the hydration 
of the membrane, that is, the ability of water to penetrate the membrane and form hydrogen 
bonds with the indicator; and 2) membrane hydration also leads to quenching of fluorescence 
from all three molecular species. In the case of F66, an increased dipole potential leads to a 
relative increase in the emission from species T* at the expense of species N*. However, these 
changes are confounded by less water quenching in lipid rafts, resulting in stronger fluorescence 
from raft-localized indicators from all three species. The dipole potential sensitive intensity ratio 
of 3-hydroxyflavone dyes is calculated as the emission in the low wavelength range divided by 
that in the high wavelength range. Both the N* and H-N species contribute to emission in the 
low wavelength range. For F66, the emission ratio is expected to be negatively correlated with 
the magnitude of the dipole potential, that is, the emission in the low and high wavelength range 
should decrease and increase, respectively, in lipid rafts compared to the bulk phase. Because 
contributions of both the N* and H-N species decrease in lipid rafts in the low-wavelength 
region, the emission ratio will change as expected. The behavior of PPZ8 differs in two respects: 
1) it has hardly any emission in the low wavelength range, leading to potential problems related 
to background subtraction and consequent misestimation of the specific fluorescence intensity; 
and 2) the higher dipole potential and less hydration in lipid rafts are expected to change the 
relative contribution of the N* and H-N bands in different directions. Because the emission from 
the dominating T* band increases because of less water quenching in lipid rafts, the emission in 
the low wavelength range of PPZ8 should increase substantially, so that its emission ratio 
displays the expected positive correlation with the higher dipole potential in lipid rafts. However, 
the intensity in the low wavelength range of PPZ8 cannot increase strongly enough owing to 
points 1–2 above.  
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The magnitude of the dipole potential has usually been estimated to be in the range 
between 200 and 500 mV. Because the estimated difference between the dipole potential inside 
and outside lipid rafts is 50–100 mV, this effect is expected to have a significant impact on how 
membrane-related phenomena, for example, transmembrane transport, signaling, and membrane 
trafficking, involving membrane proteins occur inside and outside lipid raft microdomains. 
Differences in the lipid composition and order of the membrane can influence the dipole 
potential and membrane-related phenomena not only under physiological conditions but also in 
diseases. The increase in the dipole potential associated with sphingolipid accumulation in an in 
vitro model of Gaucher’s disease was found to be similar in magnitude to the difference in the 
dipole potential inside and outside rafts. Because alterations in the cholesterol and sphingolipid 
content of the membrane in a conditional glucocerebrosidase knock-out mouse model are 
comparable to those observed in the in vitro model we applied, the presented results imply that 
pathological changes in the lipid content of the cell membrane in human diseases in general, and 
in Gaucher disease in particular, can lead to significant changes in the dipole potential and can 
also substantially modify the functioning of membrane proteins, potentially contributing to the 
development of disease symptoms. 
In conclusion, in the second phase of our experiments we have shown that the dipole 
potential is significantly larger in lipid raft microdomains than in the bulk membrane domain. 
The magnitude of this difference is large enough so that the conformation of the transmembrane 
domain of proteins is altered when they move into or out of lipid rafts. Consequently, some of 
the biological effects linked to lipid rafts can be attributed to the larger dipole potential present 
in this microdomain.  
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6. Summary 
A largely unknown component of the membrane potential, the dipole potential, is 
generated by the ordered orientation of lipid carbonyl and membrane-attached water dipole 
moments. The dipole potential, generating an electric field much stronger than any other type of 
membrane potential, influences a wide array of phenomena including voltage-dependent 
conformational changes of the transmembrane domains (TMD) of proteins. Although activation 
of ErbB receptors (ErbB1-4) is driven by oligomerization mediated by intermolecular 
interactions, the TMD has been largely neglected in this regard. The dipole potential alters the 
conformation of transmembrane peptides, but its effect on ErbB proteins was unknown.  
In our experiments, we showed using flow cytometric FRET and N&B analysis in 
confocal microscopy that the EGF-induced increase in the homoassociation of ErbB1 and ErbB2 
and their heteroassociation are augmented by increasing the dipole potential. These effects were 
even more pronounced for ErbB2 harboring an activating Val → Glu mutation in the 
transmembrane domain (NeuT). The signaling capacity of ErbB1 and ErbB2 was also correlated 
with the dipole potential. Since the dipole potential decreased the affinity of EGF to ErbB1, the 
augmented growth factor-induced effects at an elevated dipole potential were actually induced 
at lower receptor occupancy. We concluded that dimerization induced by an elevated dipole 
potential will bring about TMD-driven receptor activation leading to increased signaling 
mediated by dimers stabilized by interactions among the extracellular domains and the TMDs. 
The dipole potential may play a permissive role in the clustering of ErbB receptors, and the 
effects of lipid rafts on receptor tyrosine kinases can be partially attributed to the dipole potential. 
Theoretical considerations and indirect experimental evidence obtained in model 
membranes suggested that the dipole potential is larger in liquid-ordered domains believed to 
correspond to lipid rafts in cell membranes. Using three different dipole potential-sensitive 
fluorophores and four different labeling approaches of raft and non-raft domains we showed by 
quantitative confocal image analysis that the dipole potential is indeed stronger in lipid rafts than 
in the rest of the membrane. The magnitude of this difference seemed to be large enough so that 
the conformation of the TMD is altered when proteins move into or out of lipid rafts. The 
magnitude of this difference was similar to that observed between the dipole potential in control 
and sphingolipid-enriched cells characteristic of Gaucher’s disease, pointing to a potential 
pathophysiological role for these findings. Our results established that the heterogeneity of the 
dipole potential in living cell membranes was correlated with lipid rafts and implied that 
alterations in the lipid composition of the cell membrane in human diseases can lead to 
substantial changes in the dipole potential. 
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7. Publikációk 
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